The beta lVS-2-654 C-->T mutation accounts for approximately 20% of be
ta thalassemia mutations in southern China; it causes aberrant RNA spl
icing and leads to beta(0) thalassemia. To provide an animal model for
testing therapies for correcting splicing defects, we have used the '
'plug and socket'' method of gene targeting in murine embryonic stem c
ells to replace the two (cis) murine adult beta globin genes with a si
ngle copy of the human beta lVS-2-654 gene. No homozygous mice survive
postnatally. Heterozygous mice carrying this mutant gene produce redu
ced amounts of the mouse beta globin chains and no human beta globin,
and have a moderate form of beta thalassemia. The heterozygotes show t
he same aberrant splicing as their human counterparts and provide an a
nimal model for testing therapies to correct splicing defects at eithe
r the RNA or DNA level. (C) 1998 by The American Society of Hematology
.